Apr 17, 2023 / 09:30PM GMT
Operator
Good evening, and welcome to the Kinnate Biopharma post-AACR conference call. This conference will be recorded, and a replay along with the slides will be available on Kinnate's website following the conclusion of the event. Following the prepared remarks, we will conduct a question-and-answer session. (Operator Instructions)
I would now like to introduce your host for today's conference, Nima Farzan, Kinnate President and Chief Executive Officer. Sir, you may begin.
Nima Farzan - Kinnate Biopharma Inc. - CEO
Thank you, operator, and good evening, everyone. Thank you to those of you on the line for joining. Before we begin, I want to note we will be making forward-looking statements. Please visit kinnate.com to review our press releases and SEC filings for notes regarding forward-looking statements and associated risk factors.
Okay. I am pleased to have on the call with me Dr. Richard Williams, our Chief Medical Officer; Dr. Rob Kania, our SVP of drug discovery; Neha Krishnamohan, our CFO; and members of our Scientific Advisory Board: Dr.
Kinnate Biopharma Inc To Host AACR 2023 Virtual Investor Event Transcript
Apr 18, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers